News & Media

News
& Media

News
& Media

Announcements, coverage, videos and updates from Cytonics.

Announcements, coverage, videos and updates from Cytonics.

Videos

Featured video

CYT-108: Mechanism of Action

Cytonics: Engineering the Future of Joint Health with Molecular Precision

Mr. Wonderful Interviews Cytonics CEO Joey Bose: The Biotech Startup Taking on Big Pharma

Discover CYT-108’s “Venus Flytrap” Mechanism of Action

Why This Jiu Jitsu Icon Is Backing the Future of Osteoarthritis Treatment

Meet the Founder: How a Spine Surgeon and Jiu-Jitsu Black Belt Took on Osteoarthritis

Eve Gracie Talks Health, Healing, and Partnering with Cytonics

More on YouTube ↗

Watch more on YouTube

CTA Button

Events & Webinars

Upcoming

No upcoming events right now. Sign up for updates below and we’ll let you know.

Past

31 Jul 2025

Breaking the Pain Cycle

The Future of Joint Regeneration with Cytonics CEO Joey Bose

Zoom webinar

20 Jun 2025

Inside Cytonics

A Raw Conversation with CEO Joey Bose on Beating Osteoarthritis

Zoom webinar

12 May 2025

Biotech Meets the Bottom Line

Mr. Wonderful and Cytonics on Disrupting Osteoarthritis

YouTube

Media Inquiries

For interviews, press materials or collaboration opportunities, contact our team.

Get updates on CYT-108 and the science behind it.

The company is “testing the waters” of a potential offering which will be conducted under a valid exemption under U.S. Securities laws. No money or other consideration is being solicited, and if sent in response, will not be accepted. Reservations and/or indications of interest involve no obligation or commitment of any kind on any party. This process allows companies to determine whether there may be interest in an eventual offering of its securities. The company is not under any obligation to make an offering. It may choose to make an offering to some, but not all, of the people who indicate an interest in investing. If the company does go ahead with an offering, it will only be able to make sales after it has filed offering documents with the Securities and Exchange Commission (SEC). The information in those offering documents will be more complete than the information the company is providing now, and could differ in important ways. You must read the documents filed with the SEC before investing.

This website may contain forward-looking statements and information relating to, among other things, the company, its business plan and strategy, and its industry. These forward-looking statements are based on the beliefs of, assumptions made by, and information currently available to the company’s management. When used in the offering materials, the words “estimate,” “project,” “believe,” “anticipate,” “intend,” “expect” and similar expressions are intended to identify forward-looking statements. These statements reflect management’s current views with respect to future events and are subject to risks and uncertainties that could cause the company’s actual results to differ materially from those contained in the forward-looking statements. Investors are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date on which they are made. The company does not undertake any obligation to revise or update these forward-looking statements to reflect events or circumstances after such date or to reflect the occurrence of unanticipated events.

© 2026 Cytonics Corporation. All rights reserved.